Effect of Phytoecdysterone Administration in Subjects With Prediabetes
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
Summary
- Conditions
- Prediabetes
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: cohort populations with diagnostic metabolic syndrome treatment base with ecdysterone for 90 daysMasking: Double (Care Provider, Outcomes Assessor)Masking Description: Randomized double-blind clinical trial plus control groupPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 30 years and 60 years
- Gender
- Both males and females
Description
Subjects with a diagnosis of prediabetes are included according to the criteria of the American Diabetes Association in its version 2019, between 30 and 60 years old residents of the city of Guadalajara, Jalisco, Mexico who come to clinical nutrition consultation in the University Hospital Fray Anto...
Subjects with a diagnosis of prediabetes are included according to the criteria of the American Diabetes Association in its version 2019, between 30 and 60 years old residents of the city of Guadalajara, Jalisco, Mexico who come to clinical nutrition consultation in the University Hospital Fray Antonio Alcalde from the city of Guadalajara, Jalisco, Mexico. The study design is a randomized, randomized clinical trial with a control group in two groups: an intervention group with ecdysterone 300mg every 24 hours for 12 weeks (approximately 90 days) and an approved placebo control group (magnesia stearate) ) at 300mg every 24 hours for 12 weeks (approximately 90 days).
Tracking Information
- NCT #
- NCT03906201
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: ANA FLETES University of Guadalajara
Get Well Soon